SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-07-2130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

PEA‑15 Contributes to the Clinicopathology and AKT‑regulated Cisplatin Resistance in Gastric Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Transcriptome Profiling of Cervical Cancer Cells Acquired Resistance to Cisplatin by Deep Sequencing

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells

PLoS ONE
Multidisciplinary
2014English

The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

2012English

Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression

Oncotarget
Oncology
2019English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy